Item 7.01 Regulation FD Disclosure On August 5, 2026, Solventum Corporation issued the press release attached hereto as Exhibit 99.1 with respect to the matters set forth in Item 8.01.…
Filed Aug 5, 2026Accepted Aug 5, 2026, 4:11 PM EDTCIK 1964738Accession 0001964738-26-000043
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure
On August 5, 2026, Solventum Corporation issued the press release attached hereto as Exhibit 99.1 with respect to the matters set forth in Item 8.01.
The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events
On August 5, 2026, Solventum Corporation announced its intention to pursue a separation of its Health Information Systems business as part of the Company’s ongoing portfolio optimization strategy. The press release is attached hereunder as Exhibit 99.1 and incorporated herein by reference.